Clinical trial looking for participants for new Alzheimer's drug abc15
PHOENIX — The recent approval of a new Alzheimer's drug is opening the door for researchers to expand their work and validate the work they've already done. Now they're recruiting local study participants.
ABC15 first reported about the challenges surrounding access to the drug lecanemab, with an out-of-pocket annual cost of over $20,000. One way around the cost is to participate in a clinical trial and there is one currently taking patients in the Valley. Researchers working on the AHEAD study believe there are indicators of Alzheimer's that can show up even 20 years before the disease takes hold. They've identified a protein, detectable in blood tests, that signals your risk of Alzheimer's. Now, they need to work backward to confirm an early intervention treatment so doctors can order those blood tests. "The ease of having blood tests is obviously going to change the face of Alzheimer's care so that soon hopefully primary care doctors will be screening all individuals starting at a certain age," said Alzheimer's specialist physician Dr. Danielle Goldfarb, who is working on the AHEAD study. "The approval and demonstration by the FDA validates that we really need to start sooner before there's any symptoms," said Dr. Goldfarb. Banner Alzheimer's Institute in Phoenix and Banner Sun Health Research Institute in Sun City are participating in the study. They're recruiting people ages 55-80, without symptoms but who are at risk. There are still side-effect concerns with lecanemab that you will be monitored for. You should discuss with your doctor if participating is right for you.
Please follow us on Google to support us United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Medical experts divided on whether 2nd FDA-approved Alzheimer's drug provides a benefitThe FDA recently approved a drug that may help patients in the early stages of Alzheimer’s by slowing down the progression of the disease. But doctors and health experts are divided on whether the drug warranted an accelerated FDA approval and whether it provides a substantial benefit.
Read more »
NHS: More cancer specialists needed in A&E, doctors saySide effects of immunotherapy could have killed Imogen, if specialists were not on hand to help.
Read more »
Clinical psychiatrist breaks down impacts following Monterey Park mass shootingClinical psychiatrist breaks down mental health impacts following Monterey Park mass shooting. Dr. Shiva Ghaed survived 2017 Las Vegas mass shooting and has been in the field 20 years.
Read more »
Major Blow as Experimental HIV Vaccine Fails in Late Clinical TrialThe decades-long quest to develop a HIV vaccine has been dealt another major blow, with the 'last true candidate in development' failing to prevent infections any better than a placebo in late-stage clinical trials.
Read more »
This Political Crafter Inspires Activists With Her Protest Banner Lending LibraryArtist, writer, and educator, Aram Han Sifuentes, weaves inspiration into her art with gorgeous ease. Read more about her Protest Banner Lending Library!
Read more »
Sundance 2023 Review: Birth/RebirthSundance brings maternal horror with a clinical twist in Birth/Rebirth.
Read more »